Dr. Marc L. Ladenheim, MD

Dr. Ladenheim practices at Providence Saint Joseph Medical Center in Burbank, California, part of Providence Health & Services.

Dr. Ladenheim's NPI, 1558363416, was assigned on August 11, 2005. Dr. Ladenheim graduated from University of Rochester Medical Center in 1979. Dr. Ladenheim holds California license G049875.

Dr. Ladenheim's primary practice is Providence Saint Joseph Medical Center, at 501 South Buena Vista Street, Burbank, CA 91505 in Los Angeles County. The practice phone is (818) 843-5111.

Dr. Ladenheim's primary practice is Providence Saint Joseph Medical Center in Burbank, California, part of Providence Health & Services. The medical group on file is Adventist Health Glendale. Dmand AI also links Dr. Ladenheim to 1 more physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ladenheim practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Ladenheim's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Ladenheim is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Ladenheim is licensed in California.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cerebrovascular disease, chronic hypertension, congestive heart failure, coronary artery disease, heart blockage and heart failure among the conditions Dr. Ladenheim treats.

CMS data shows 546 Medicare services from Dr. Ladenheim across 11 procedure codes in 2024, for 182 Medicare patients. Medicare paid $45,233 for them. Every service was in an office.

CMS counts 182 Medicare patients who saw Dr. Ladenheim in 2024. The largest group is 75 to 84, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ladenheim's median patient age at 74, with 44% women.

In 2024, Dr. Ladenheim wrote 2,846 Medicare Part D claims for 257 patients. 83% of them were for generic drugs. CMS names the drug for 2,483 of them, across 67 drugs with 11 or more claims each, at $420,755 in total drug cost. In 2023, CMS named 3,588 claims across 75 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ladenheim for performance year 2024, reported individually.

Dmand AI links 4 papers to Dr. Ladenheim. The most frequent topics are Coronary Disease. Dr. Ladenheim has published most often in J Am Coll Cardiol. Dr. Ladenheim's most frequent co-authors are Eli S. Gang, MD, William J. Mandel, MD and Peter C. Nalos, MD.

CMS Open Payments shows 753 general payments to Dr. Ladenheim from 64 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 71% of the total. Medtronic, Inc. paid the most, $5,544.

Dmand AI lists 1 award for Dr. Ladenheim, most recently CMS Stage 1 2012 in 2012.

Dr. Ladenheim graduated from University of Rochester Medical Center in 1979.

Dr. Ladenheim is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.